Skip Navigation



JAC Advance Access published online on June 13, 2009
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkp203
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
64/2/267    most recent
dkp203v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patel, E. H.
Right arrow Articles by Abratt, V. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, E. H.
Right arrow Articles by Abratt, V. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Original research

Overexpression of the rhamnose catabolism regulatory protein, RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron

Ekta H. Patel1, Lynthia V. Paul1, Ana I. Casanueva1, Sheila Patrick2 and Valerie R. Abratt1,*

1 Department of Molecular and Cellular Biology, University of Cape Town, Rondebosch, South Africa 2 Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast BT9 7BL, UK

* Corresponding author. Tel: +27-21-650-2183; Fax: +27-21-689-7573; E-mail: valerie.abratt{at}uct.ac.za

Received 2 March 2009; returned 26 March 2009; revised 11 May 2009; accepted 12 May 2009


   Abstract
Top
 Abstract
Introduction
 Methods
 Results and discussion
 Funding
 Transparency declarations
 References
 
Objectives: The aim of the investigation was to use in vitro transposon mutagenesis to generate metronidazole resistance in the obligately anaerobic pathogenic bacterium Bacteroides thetaiotaomicron, and to identify the genes involved to enable investigation of potential mechanisms for the generation of metronidazole resistance.

Methods: The genes affected by the transposon insertion were identified by plasmid rescue and sequencing. Expression levels of the relevant genes were determined by semi-quantitative RNA hybridization and catabolic activity by lactate dehydrogenase/pyruvate oxidoreductase assays.

Results: A metronidazole-resistant mutant was isolated and the transposon insertion site was identified in an intergenic region between the rhaO and rhaR genes of the gene cluster involved in the uptake and catabolism of rhamnose. Metronidazole resistance was observed during growth in defined medium containing either rhamnose or glucose. The metronidazole-resistant mutant showed improved growth in the presence of rhamnose as compared with the wild-type parent. There was increased transcription of all genes of the rhamnose gene cluster in the presence of rhamnose and glucose, likely due to the transposon providing an additional promoter for the rhaR gene, encoding the positive transcriptional regulator of the rhamnose operon. The B. thetaiotaomicron metronidazole resistance phenotype was recreated by overexpressing the rhaR gene in the B. thetaiotaomicron wild-type parent. Both the metronidazole-resistant transposon mutant and RhaR overexpression strains displayed a phenotype of higher lactate dehydrogenase and lower pyruvate oxidoreductase activity in comparison with the parent strain during growth in rhamnose.

Conclusions: These data indicate that overexpression of the rhaR gene generates metronidazole resistance in B. thetaiotaomicron

Key Words: antibiotic resistance , anaerobes , rhamnose regulation


   Introduction
Top
 Abstract
 Introduction
Methods
 Results and discussion
 Funding
 Transparency declarations
 References
 
Bacteroides fragilis and Bacteroides thetaiotaomicron are members of the normal resident gastrointestinal microbiota, and are important opportunistic pathogens that are capable of causing life-threatening infections such as peritonitis, serious gynaecological sepsis, bacteraemia, and soft tissue and brain abscesses.1,2 Metronidazole [1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole] is commonly used in the treatment of these anaerobic microbial infections. In addition, it is used for routine prophylaxis during gastrointestinal tract and gynaecological surgery. It is administered as an inert prodrug that is activated intracellularly under anaerobic conditions by the reduction of its nitro group. This generates an active toxic derivative, which causes single- and double-strand DNA breaks.3 In certain anaerobic protozoa, activation of metronidazole involves a low intracellular redox potential process that results in the reduction of the 5-nitro group forming the transient toxic radicals.4 The imidazole ring structure is thought to fragment producing two short-lived cytotoxic intermediates, acetamide and N-(2-hydroxyethyl)-oxamic acid.5–7 Activation of the drug is likely to occur through interaction with a pyruvate oxidoreductase complex in an ATP-dependent reaction.4,8 The pyruvate oxidoreductase complex is formed by a metabolic reaction between pyruvate and the oxidoreductase enzyme to facilitate pyruvate decarboxylation to form acetyl CoA. This reaction generates electrons that are accepted by ferredoxins or flavodoxins that have electron efficiency of –430 or –460 mV.5 Studies on several B. fragilis species suggest that metronidazole activation occurs at a similar pyruvate oxidoreductase complex.8–10 Bacteroides spp. can develop resistance to metronidazole via acquisition of nitroimidazole resistance genes (nim) that may be encoded on mobile genetic elements (reviewed by Patrick11). These encode a reductase that converts the nitro group of metronidazole into an amine, thus rendering it inactive.3

Overexpression of efflux pumps is known to play a role in the resistance of Bacteroides spp. to a range of antibiotics.1 While this may also confer resistance to metronidazole, efflux pump inhibitors did not restore metronidazole susceptibility in a multiresistant B. fragilis that lacked nim genes,12 suggesting that there are alternative mechanisms of resistance. In this study, we report the isolation and characterization of a B. thetaiotaomicron metronidazole-resistant mutant. We demonstrate for the first time a link between metronidazole resistance, the rhamnose catabolic pathway and the pyruvate oxidoreductase complex, and the overexpression of the regulator of the rhamnose catabolic pathway, RhaR.


   Methods
Top
 Abstract
 Introduction
 Methods
Results and discussion
 Funding
 Transparency declarations
 References
 
Bacterial cultivation, strains and plasmids

The bacterial strains and plasmids used in this study are listed in Table 1.


View this table:
[in this window]
[in a new window]

  		Table 1. Bacterial strains and plasmids

 
B. thetaiotaomicron cultures were grown anaerobically in brain heart infusion broth supplemented with haemin, menadione and cysteine (BHIS) or BHIS agar (1.5% w/v)13 as previously described.14 Escherichia coli strains were grown with aeration in Luria-Bertani (LB) broth15 or on LB agar plates (1.5% w/v) at 37°C. The antibiotics gentamicin (200 mg/L), ampicillin (100 mg/L), tetracycline (2 mg/L) and erythromycin (10 mg/L) were added to BHIS or LB whenever necessary. E. coli strains carrying plasmids were grown in LB medium supplemented with ampicillin (100 mg/L). Carbohydrate utilization studies were performed by growing B. thetaiotaomicron in defined medium (DM)16 supplemented with 0.1% of either glucose (DMG) or rhamnose (DMR) (Sigma-Aldrich) as the sole carbon source. Growth of the organisms was measured as an increase in optical density at 600 nm (OD600) over time. Metronidazole survival studies were performed by growing B. thetaiotaomicron cultures to mid-exponential phase in DMR or DMG broth followed by exposure to 15 mg/L metronidazole. Viable counts were determined anaerobically at various timepoints by plating culture dilutions in triplicate on BHIS agar plates and incubation at 37°C for 72 h.

Tn4400' transposon mutagenesis, Southern hybridization and identification of the transposon insertion site

The construction of a B. thetaiotaomicron VPI-5482 transposon mutant library was carried out using the transposon delivery vector, pYT646B, and the conjugation mutagenesis method of Tang and Malamy.17 Selection of the transconjugant colonies was performed anaerobically by plating the conjugation mixture onto BHIS agar plates containing gentamicin and either tetracycline or erythromycin. Plasmid rescue was carried out according to Chen et al.18 Putative metronidazole-resistant mutants were screened on BHIS agar plates containing metronidazole ranging in concentration from 0.5 to 8 mg/L. The mutant B. thetaiotaomicron Tn MetR was selected for further study. Southern blot analysis was performed according to standard protocols15 using genomic DNA (20 µg) of both B. thetaiotaomicron VPI-5482 and the B. thetaiotaomicron Tn MetR mutant, as well as 20 ng of the 13.1 kb transposon delivery vector, pYT646B, each digested to completion with restriction enzyme PvuII.15 B. thetaiotaomicron total genomic DNA was prepared according to the method of Wehnert et al.19 and E. coli plasmid DNA was prepared by the alkali-hydrolysis method of Ish-Horowicz and Burke.20 The DNA probe used for hybridization was a 0.9 kb internal fragment of the pYT646B tetQ gene generated by digesting it with SacI and EcoRI. Hybridization and detection procedures were performed according to the manufacturers' instructions. For identification of the transposon insertion site, genomic DNA from the mutant was digested with HindIII and the fragment adjacent to the transposon was isolated by plasmid rescue.18 The chromosomal DNA in the resulting ampicillin-resistant plasmid was sequenced using primer L58, derived from IS4400R in the transposon.18 The primers listed in Table 2 were used to amplify the 5' and 3' junction ends of the transposon insertion in the B. thetaiotaomicron Tn metR chromosomal DNA. The PCR fragments obtained were purified using the High Pure PCR Cleanup Kit (Roche) and sequenced as previously described.14 B. thetaiotaomicron VPI-5482 sequence data were obtained from the NCBI website (GenBank accession number NC_004663 [GenBank] ). Analysis was done using the BLAST algorithm21 and DNAMAN software V4.13.


View this table:
[in this window]
[in a new window]

  		Table 2. Oligonucleotides used for PCR

 
RNA extraction and semi-quantitative dot blot hybridization

B. thetaiotaomicron wild-type and mutant cells for RNA extraction were grown anaerobically to late exponential phase in DMR or DMG and the total RNA was isolated.14 RNA was treated with DNaseI and quantified using the NanoDrop® ND-100 spectrophotometer (NanoDrop Technologies, Inc.). For semi-quantitative RNA hybridization studies, equal amounts (1 µg) of the B. thetaiotaomicron RNA were spotted in equal volumes (2 µL) onto a nylon membrane (Roche). Hybridization and detection procedures were performed according to the manufacturer's instructions (Roche). Internal fragments of the genes of interest were used as DNA probes for transcriptional hybridization studies. These were prepared by PCR amplification using gene-specific primers (Table 2). The 16S rRNA gene of B. thetaiotaomicron VPI-5482 was used as an internal control (Table 2). The PCR, DNA hybridization, detection procedures and analysis were carried out as previously described by Patel et al.14 Signal intensities were measured using a densitometer and analysed with GeneSnap 6.05 software (Synoptics Ltd). Results from duplicate experiments were expressed as the ratio of the gene-specific transcription signal of mutant cells as compared with wild-type cells (induction ratio).

Construction of B. thetaiotaomicron rhaR overexpresser strain

The full-length rhaR gene, including 239 bp upstream of the gene, was PCR amplified using primers cRF and cRR (Table 2). The PCR product was digested with HindIII and XmnI, cloned into the HindIII and SmaI sites of the shuttle vector pLYL0122 and transformed into E. coli DH5{alpha}. The resultant plasmid, pLYLrhaR, was extracted, purified and retransformed into E. coli S17-1 according to standard methods.15 Mobilization of pLYLrhaR from E. coli S17-1 (pLYLrhaR) into B. thetaiotaomicron VPI-5482 was performed by the conjugation procedure of Li et al.22 The resulting transconjugant, B. thetaiotaomicron rhaR(+), was grown on BHIS agar with tetracycline (2 mg/L).

Preparation of cell-free extracts (CFEs) and enzyme assays

B. thetaiotaomicron VPI-5482 cultures for CFEs were grown anaerobically to late log phase in DMR broth. Cells were harvested by centrifugation (8 K, 4°C, 10 min). Pellets were washed three times under anaerobic conditions in 10 mM Tris–HCl, pH 8.0 (for the lactate dehydrogenase assay) or 10 mM phosphate buffer with 250 µM β-mercaptoethanol, pH 7.0 (for the pyruvate oxidoreductase assay), and resuspended in 5 mL of the same buffers, respectively. Cells were disrupted by sonication using an MSE sonicator at an amplitude of 18–24 µm for periods of 30 s/mL of cell suspension in tubes chilled at 0°C. Cell debris was removed by centrifugation (8 K, 4°C, 20 min). The supernatant was collected (CFE) and protein concentrations were determined using Bio-Rad reagents according to the manufacturer's instructions (Bio-Rad Laboratories). Lactate dehydrogenase activity was measured anaerobically at 37°C by the rate of decrease in absorbance of NADH at a wavelength of 340 nm using a Beckman DU®530 Lifescience UV/Vis Spectrophotometer according to the method of Abbe et al.23 Enzyme activity was recorded as µM NADH/mg of protein/min at 340 nm. Pyruvate oxidoreductase activity was measured spectrophotometrically at an absorbance of 600 nm using a Beckman DU®530 Lifescience UV/Vis Spectrophotometer, with methyl viologen as the electron acceptor at 37°C under anaerobic conditions using the method of Lindmark and Müller.24 The enzyme activity was recorded as µM methyl viologen/mg of protein/min at 600 nm. All the experiments were performed in triplicate.


   Results and discussion
Top
 Abstract
 Introduction
 Methods
 Results and discussion
Funding
 Transparency declarations
 References
 
Isolation of the metronidazole-resistant B. thetaiotaomicron mutant

Transposon mutagenesis was used to create metronidazole-resistant B. thetaiotaomicron mutants.17 Tetracycline-resistant transconjugants were detected at frequencies of 2 x 10–6 to 4 x 10–5 per E. coli donor cell. An average of 40% of tetracycline-resistant transconjugants were co-integrates, compared with the 4% co-integrate formation in B. fragilis reported by Tang and Malamy.17 The B. thetaiotaomicron transposon mutant bank (~2000 isolates) was screened for metronidazole resistance on BHIS agar using metronidazole concentrations varying from 0.5 to 8 mg/L. A mutant, B. thetaiotaomicron Tn MetR, was isolated with an MIC of 8 mg/L metronidazole compared with the wild-type, which had an MIC of 0.8 mg/L.

Location of the transposon insertion

Southern hybridization confirmed the presence of a single transposon insertion within the chromosome of the B. thetaiotaomicron Tn MetR mutant (data not shown). Plasmid rescue and junction PCR of the chromosomal DNA were performed in order to determine the precise location of the transposon within the mutant. The transposon insertion was found to be 141 bp upstream of rhaR, the gene encoding the positive transcriptional regulator of rhamnose catabolism in B. thetaiotaomicron (Figure 1a and b). We have demonstrated previously that this region contains the rhaR gene promoter sequence.14


Figure 1
View larger version (7K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 1. Genomic arrangement of the rhamnose gene cluster in B. thetaiotaomicron VPI-5482 (accession number NC 004663) and the B. thetaiotaomicron Tn MetR metronidazole-resistant mutant. (a) Position of the transposon insertion site. PKIAPO and PR indicate the two promoters that have been identified using sequencing and bioinformatic analysis.14 The dashed arrow shows the position of the Tn4400' transposon insertion. (b) Schematic representation (not to scale) of the transposon insertion between rhaO and rhaR. IS4400L and IS4400R, insertion sequence elements; arrows indicate positions of primers used to confirm the insertion site (Table 2); tetQ, gene expressing tetracycline resistance in Bacteroides species; bla, gene expressing β-lactamase (ampicillin resistance) in E. coli; rhaO and rhaR, chromosomal genes of B. thetaiotaomicron VPI-5482.

 
Growth studies under inducing conditions

Growth studies were performed in order to investigate the effect of L-rhamnose or D-glucose on the growth of the metronidazole-resistant mutant. Results indicated that the mutant strain grown in DMR attained a higher cell density after 10 h when compared with the parent strain, with OD600 values of 1.00 ± 0.02 and 0.65 ± 0.03, respectively. There was no significant difference in the cell density of the wild-type and mutant when cells were grown in DMG. This observation suggested that the transposon was improving the capacity of the cells to utilize rhamnose, possibly through increasing the levels of RhaR, the positive transcriptional regulator. The transposon did not, however, appear to affect the catabolism of glucose in the mutant cells.

Effect of the transposon on transcription

The levels of transcription of the genes of the rhamnose cluster were examined to determine if this was related to the enhanced growth of the MetR mutant when compared with the wild-type. Semi-quantitative transcriptional dot blot hybridization studies were performed using RNA extracted from cells grown in DMR or DMG. Results indicated that the transposon insertion in the intergenic region upstream of rhaR caused increased transcription of all the rhamnose genes in B. thetaiotaomicron Tn MetR as compared with the wild-type strain. In the presence of rhamnose, the genes rhaKIPAOR all showed an increase in transcription, expressed as induction ratios of mutant versus wild-type, of 3.4, 3.8, 3.4, 4.4, 3.4 and 1.7, respectively. During growth in glucose, an increase in transcription of these genes was also seen, with induction ratios of 11.1, 19.5, 14.4, 18.8, 15.5 and 1.5, respectively. The internal control 16S rRNA gene was transcribed at the same level in both wild-type and mutant strains under both growth conditions. The results show that even a relatively low level of increase in transcription of the positive regulator, RhaR, can bring about higher levels of transcription of all the genes of the rhamnose operon, even in the absence of rhamnose. In the presence of rhamnose, increased transcription resulted in improved utilization of the substrate and hence better growth as compared with the wild-type parent. During growth in glucose, the increased transcription of the rhamnose catabolic genes brought no additional nutrient benefit to the mutant cells and the same growth response as the wild-type was observed.

Based on the location of the transposon and the orientation of IS4400L relative to the transcriptional direction of rhaR (Figure 1b), it is possible that the IS element could be acting as an additional promoter leading to increased transcription. Figure 2 illustrates the DNA sequence obtained from sequence analysis of the transposon insertion site relative to the rhaR promoter region and coding sequence. Three possible typical Bacteroides putative –7 hexamers (consensus TAnnTTTG) were identified within the IS4400L sequence. This is in keeping with the findings of Bayley et al.25 who first described the B. fragilis consensus promoter and reported its presence in the IS4351 element, which is identical to IS4400 used in this study. It is not unusual for IS elements to act as strong promoters and activate genes26,27 and their role in naturally occurring antibiotic resistance is well documented. For example, Haggoud et al.28 first identified the IS1168 insertion sequence as being located upstream of the nitroimidazole resistance genes (nim), and Soki et al.29 reported that nine nimA genes were activated by IS1168 and three of the nimC genes were activated by IS1170. In B. fragilis, Rogers et al.30 associated the IS1224 insertion upstream of the cepA β-lactamase gene with up-regulation and Podglajen et al.31 reported that IS1186 activated the expression of the metallo-β-lactamase cfiA gene, causing resistance to carbapenems. They later identified the typical Bacteroides consensus promoter sequences within two IS elements, IS1187 and IS1188, that were found upstream of cfiA.32 Based on the analysis of the IS4400L in relation to RhaR, it is likely that these consensus promoter elements within the IS4400 element are increasing the activation of the rhaR gene, as observed in the transcriptional studies.


Figure 2
View larger version (12K):
[in this window]
[in a new window]
[Download PowerPoint slide]
  		Figure 2. Position of IS4400L in relation to the transcriptional start site of rhaR. Nucleotide sequence of IS4400L (italics) upstream of the B. thetaiotaomicron rhaR promoter region and nucleotide sequence; –7 and –33 promoter recognition sequences, the +1 transcriptional start site (bold underlined) and the ATG start codon of rhaR (bold, box) are shown. The putative –7 hexamers within the IS element are shown in bold italics and are underlined.38

 
Metronidazole resistance

The transposon insertion in the intergenic region between rhaO and rhaR was shown to increase the transcription of the rhamnose genes in B. thetaiotaomicron Tn MetR. It was, therefore, possible that higher levels of RhaR were causing the metronidazole resistance phenotype. In order to test this hypothesis, RhaR, the positive transcriptional regulator of the rhamnose operon,14 with its putative promoter region, was overexpressed in B. thetaiotaomicron VPI-5482 through introducing the rhaR gene into the parent strain on a multicopy plasmid to create B. thetaiotaomicron rhaR(+). Overexpression of the rhamnose genes in this strain was tested at the transcriptional level in defined medium supplemented with rhamnose, and the results indicated that overexpression of the RhaR protein resulted in increased transcription of these genes (data not shown). In order to test the metronidazole resistance phenotype, cells grown in defined medium supplemented with rhamnose or glucose were exposed to 15 mg/L metronidazole for 40 min. Results showed that the log10 of the surviving fractions of the B. thetaiotaomicron Tn MetR mutant and B. thetaiotaomicron rhaR(+), grown in DMR, were –1.65 (±0.007) and –1.88 (±0.010), respectively. These were more resistant than the parent strain, which had a log10 surviving fraction of only –2.78 (±0.001). The B. thetaiotaomicron Tn MetR mutant cells grown in DMG also showed metronidazole resistance relative to the parental strain, with the log surviving fractions of the mutant and wild-type being –1.75 (±0.013) and –2.62 (±0.001), respectively. This result supports the previously observed metronidazole resistance during isolation of the mutant on BHIS agar, a glucose-containing medium. These data represent the mean values of three experiments, with the standard deviation for the experiments shown in brackets. These results confirm the relationship between increased levels of RhaR and the observed metronidazole resistance, and demonstrate that the phenotype is not directly dependent on the catabolism of rhamnose, but suggest an additional as yet unknown regulatory role for the RhaR protein in relation to metronidazole resistance.

Pyruvate oxidoreductase and lactate dehydrogenase activity

The improved growth and a metronidazole resistance phenotype observed in both B. thetaiotaomicron Tn MetR and B. thetaiotaomicron rhaR(+) during growth in the presence rhamnose could be due to increased expression of RhaR affecting the enzymes responsible for metronidazole activation. Given the proposed role of pyruvate oxidoreductase in metronidazole activation in anaerobes, and the role of lactate dehydrogenase in catabolism, biochemical assays were undertaken to determine the activity of the lactate dehydrogenase and pyruvate oxidoreductase in the metronidazole-resistant strains during growth in DMR (Table 3). The results showed that the lactate dehydrogenase activity of B. thetaiotaomicron Tn MetR and B. thetaiotaomicron rhaR(+), during growth in DMR, was 4–5 times higher than B. thetaiotaomicron VPI-5482, whereas pyruvate oxidoreductase activity in these resistant strains was 7–10 times lower in comparison with the parent strain (Table 3). These results suggested that the lower pyruvate oxidoreductase activity observed in the resistant strains could be contributing to the observed metronidazole resistance phenotype through a lack of metronidazole activation.


View this table:
[in this window]
[in a new window]

  		Table 3. Enzymatic activity of lactate dehydrogenase and pyruvate oxidoreductase during growth in rhamnose

 
The mechanism of metronidazole resistance in bacteria is not well understood. However, in vitro studies have shown that resistant strains displayed higher levels of lactate or lactate dehydrogenase and, on occasion, no detectable levels of pyruvate oxidoreductase, a key enzyme that is thought to activate metronidazole.5 There have been no previous reports on lactate dehydrogenase or pyruvate oxidoreductase activity in any B. thetaiotaomicron metronidazole-resistant strains. Narikawa et al.,9 however, reported high levels of lactate dehydrogenase in a B. fragilis metronidazole-resistant strain. In a more recent study, Diniz et al.8 studied a B. fragilis metronidazole-resistant mutant strain, generated by exposure to a sub-lethal concentration of metronidazole, and reported that lactate dehydrogenase activity was up-regulated, but flavodoxin was down-regulated, and there was no detectable pyruvate oxidoreductase activity in the resistant strain. They could not, however, recreate the level of metronidazole resistance observed in the spontaneous mutant by targeted genetic knock-out of either the pyruvate-ferredoxin oxidoreductase gene (porA) or flavodoxin genes. It is, therefore, possible that during growth in rhamnose metronidazole resistance in B. thetaiotaomicron Tn MetR and B. thetaiotaomicron rhaR(+) could be attributed to the lack of metronidazole activation via an altered electron flux driven by the up-regulation of rhamnose catabolism. It is possible that any mutations that give rise to the up-regulation of catabolic pathways associated with a concomitant decrease in pyruvate oxidoreductase activity generate metronidazole resistance within the Bacteroides spp.

The metronidazole resistance phenotype was, however, also seen in the B. thetaiotaomicron Tn MetR mutant cells grown in glucose, where the products of rhamnose catabolism would not have been a factor. While the results in the presence of rhamnose suggested that resistance was potentially due to reduced activation of metronidazole, the fact that the resistance phenotype was also observed in the presence of glucose makes this unlikely. It is, therefore, probable that the RhaR protein encoded by the rhaR gene may also possess additional, as yet unidentified, regulatory functions outside of the rhamnose operon that could affect the cellular responses to metronidazole. Xu et al.33 analysed the B. thetaiotaomicron genome sequence and observed that transcriptional regulatory genes, many of them of unknown function, are particularly well represented. We have previously reported that the RhaR protein shows conserved consensus domains typical of transcriptional regulators from the AraC helix-turn-helix (AraC/XylS) family of one-component sensor-regulator proteins.14 Members of the AraC family have been characterized as being involved in regulating three types of systems, namely pathogenesis, carbon metabolism and certain stress responses, and in the context of regulating stress responses, the proteins exert their regulatory role only when they are overproduced.34,35 We have previously shown that the reg gene product of B. fragilis, also a member of the AraC family, although lacking the putative cupin superfamily domain, is involved in cell survival following exposure to several damaging agents, including metronidazole.36 An equivalent gene, BT 1847, is present in the B. thetaiotaomicron genome. It remains to be determined if overexpression of the RhaR protein of B. thetaiotaomicron Tn MetR is functioning in a similar way to improve cell survival in the presence of metronidazole damage by inducing transcription of other, as yet unidentified, genes. Future work will involve proteomic comparison of the B. thetaiotaomicron wild-type and B. thetaiotaomicron Tn MetR mutant strains to identify the proteins that are up-regulated in response to the overexpression of the RhaR protein.

This is the first study to report a link between a carbohydrate catabolism regulatory protein and metronidazole resistance and presents a potentially novel mechanism for the generation of metronidazole resistance in Bacteroides spp.


   Funding
Top
 Abstract
 Introduction
 Methods
 Results and discussion
 Funding
Transparency declarations
 References
 
This study was supported by a Wellcome Trust grant (070375/Z/03/Z) and a grant from the South African Medical Research Council.


   Transparency declarations
Top
 Abstract
 Introduction
 Methods
 Results and discussion
 Funding
 Transparency declarations
References
 
None to declare.


   Acknowledgements
 
This work was previously presented at ‘Anaerobe 2007’ a joint symposium of the Society for Anaerobic Microbiology and the Society for General Microbiology, Edinburgh, Scotland, UK.

We would like to thank A. A. Salyers and N. B. Shoemaker (Urbana, IL, USA) for providing the pLYL01 plasmid and M. H. Malamy (Boston, MA, USA) for providing the plasmid pYT646B.


   References
Top
 Abstract
 Introduction
 Methods
 Results and discussion
 Funding
 Transparency declarations
 References
 
1 . Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev (2007) 20:593–621.[Abstract/Free Full Text]

2 . Patrick S, Duerden BI. Gram-negative non-spore forming obligate anaerobes. In: Principles and Practice of Clinical Bacteriology—Gillespie SH, Hawkey P, eds. (2006) London: Wiley. 541–56.

3 . Leiros HK, Kozielski-Stuhrmann S, Kapp U, et al. Structural basis of 5-nitroimidazole antibiotic resistance: the crystal structure of NimA from Deinococcus radiodurans. J Biol Chem (2004) 279:55840–9.[Abstract/Free Full Text]

4 . Upcroft JA, Dunn LA, Wright JM, et al. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob Agents Chemother (2006) 50:344–7.[Abstract/Free Full Text]

5 . Edwards DI. Nitroimidazole drugs—action and resistance mechanisms. II. Mechanisms of resistance. J Antimicrob Chemother (1993) 31:201–10.[Free Full Text]

6 . Muller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery (1983) 93:165–71.[Web of Science][Medline]

7 . Koch RL, Goldman P. The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid. J Pharmacol Exp Ther (1979) 208:406–10.[Abstract/Free Full Text]

8 . Diniz CG, Farias LM, Carvalho MA, et al. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J Antimicrob Chemother (2004) 54:100–8.[Abstract/Free Full Text]

9 . Narikawa S, Suzuki T, Yamamoto M, et al. Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295. J Antimicrob Chemother (1991) 28:47–53.[Abstract/Free Full Text]

10 . Britz ML, Wilkinson RG. Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis. Antimicrob Agents Chemother (1979) 16:19–27.[Abstract/Free Full Text]

11 . Patrick S. Bacteroides. In: Molecular Medical Microbiology—Sussman M, ed. (2002) London: Academic Press. 1921–48.

12 . Pumbwe L, Wareham DW, Aduse-Opoku J, et al. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin Microbiol Infect (2007) 13:183–9.[Web of Science][Medline]

13 . Holdeman LV, Moore WEC. Anaerobe Laboratory Manual (1972) Blacksburg, VA: Virginia Polytechnic Institute and State University Anaerobe Laboratory.

14 . Patel EH, Paul LV, Patrick S, et al. Rhamnose catabolism in Bacteroides thetaiotaomicron is controlled by the positive transcriptional regulator RhaR. Res Microbiol (2008) 159:678–84.[Medline]

15 . Sambrook JT, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual (1989) Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.

16 . Van Tassell RL, Wilkins TD. Isolation of auxotrophs of Bacteroides fragilis. Can J Microbiol (1978) 24:1619–21.[Web of Science][Medline]

17 . Tang YP, Malamy MH. Isolation of Bacteroides fragilis mutants with in vivo growth defects by using Tn4400', a modified Tn4400 transposition system, and a new screening method. Infect Immun (2000) 68:415–9.[Abstract/Free Full Text]

18 . Chen T, Dong H, Tang YP, et al. Identification and cloning of genes from Porphyromonas gingivalis after mutagenesis with a modified Tn4400 transposon from Bacteroides fragilis. Infect Immun (2000) 68:420–3.[Abstract/Free Full Text]

19 . Wehnert GU, Abratt VR, Woods DR. Molecular analysis of a gene from Bacteroides fragilis involved in metronidazole resistance in Escherichia coli. Plasmid (1992) 27:242–5.[CrossRef][Web of Science][Medline]

20 . Ish-Horowicz D, Burke JF. Rapid and efficient cosmid cloning. Nucleic Acids Res (1981) 9:2989–98.[Abstract/Free Full Text]

21 . Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 25:3389–402.[Abstract/Free Full Text]

22 . Li LY, Shoemaker NB, Salyers AA. Location and characteristics of the transfer region of a Bacteroides conjugative transposon and regulation of transfer genes. J Bacteriol (1995) 177:4992–9.[Abstract/Free Full Text]

23 . Abbe K, Takahashi S, Yamada T. Involvement of oxygen-sensitive pyruvate formate-lyase in mixed-acid fermentation by Streptococcus mutans under strictly anaerobic conditions. J Bacteriol (1982) 152:175–82.[Abstract/Free Full Text]

24 . Lindmark DG, Müller M. Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J Biol Chem (1973) 248:7724–8.[Abstract/Free Full Text]

25 . Bayley DP, Rocha ER, Smith CJ. Analysis of cepA and other Bacteroides fragilis genes reveals a unique promoter structure. FEMS Microbiol Lett (2000) 193:149–54.[CrossRef][Web of Science][Medline]

26 . Mahillon J, Leonard C, Chandler M. IS elements as constituents of bacterial genomes. Res Microbiol (1999) 150:675–87.[Medline]

27 . Schneider D, Lenski RE. Dynamics of insertion sequence elements during experimental evolution of bacteria. Res Microbiol (2004) 155:319–27.[Medline]

28 . Haggoud A, Reysset G, Azeddoug H, et al. Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob Agents Chemother (1994) 38:1047–51.[Abstract/Free Full Text]

29 . Soki J, Gal M, Brazier JS, et al. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J Antimicrob Chemother (2006) 57:212–20.[Abstract/Free Full Text]

30 . Rogers MB, Bennett TK, Payne CM, et al. Insertional activation of cepA leads to high-level β-lactamase expression in Bacteroides fragilis clinical isolates. J Bacteriol (1994) 176:4376–84.[Abstract/Free Full Text]

31 . Podglajen I, Breuil J, Collatz E. Insertion of a novel DNA sequence, IS1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol (1994) 12:105–14.[Web of Science][Medline]

32 . Podglajen I, Breuil J, Rohaut A, et al. Multiple mobile promoter regions for the rare carbapenem resistance gene of Bacteroides fragilis. J Bacteriol (2001) 183:3531–5.[Abstract/Free Full Text]

33 . Xu J, Bjursell MK, Himrod J, et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science (2003) 299:2074–6.[Abstract/Free Full Text]

34 . Gallegos MT, Schleif R, Bairoch A, et al. AraC/XylS family of transcriptional regulators. Microbiol Mol Biol Rev (1997) 61:393–410.[Abstract]

35 . Santos CL, Tavares F, Thioulouse J, et al. A phylogenomic analysis of bacterial helix-turn-helix transcription factors. FEMS Microbiol Rev (2009) 33:411–29.[CrossRef][Web of Science][Medline]

36 . Casanueva AI, Paul L, Patrick S, et al. An AraC/XylS family transcriptional regulator homologue from Bacteroides fragilis is associated with cell survival following DNA damage. FEMS Microbiol Lett (2008) 278:249–56.[CrossRef][Web of Science][Medline]

37 . Simon R, Priefer U, Puhler A. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology (1983) 1:784–91.[CrossRef]

38 . Mahillon J, Chandler M., Insertion sequences. Microbiol Mol Biol Rev (1998) 62:725–74.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
64/2/267    most recent
dkp203v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patel, E. H.
Right arrow Articles by Abratt, V. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, E. H.
Right arrow Articles by Abratt, V. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?